Adriana Brondani da Rocha

Author

Also Known As

A B Rocha, A Brondani da Rocha, A. B. Da Rocha, A. B. da Rocha, A. Brondani da Rocha, A.B. Rocha, Adriana B da Rocha, Adriana B. Rocha, Adriana B. da Rocha, Adriana Barbosa da Rocha

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Universidade Luterana do Brasil Universidade Federal do Rio Grande do Sul Hospital de Clínicas de Porto Alegre Max Delbrück Center Pontifícia Universidade Católica do Rio Grande do Sul

About

Adriana Brondani da Rocha is an author at Universidade Luterana do Brasil specializing in medicine, cancer research, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	922
2	Health Sciences	3	3	134
3	Natural Sciences	3	3	159
4	Engineering	1	1	96
5	Biomolecular Engineering	1	1	91

Adriana Brondani da Rocha

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Anti-Cancer Drug Discovery and Development in Brazil: Targeted Plant Collection as a Rational Strategy to Acquire Candidate Anti-Cancer Compounds Dennis R.A. Mans, Adriana Brondani da Rocha, Gilberto Schwartsmann The Oncologist Anti-cancer Drug DevelopmentChemoprevention StrategyAnti-cancer Drug DiscoveryMedicinal ChemistryOncology	2000	256
Anticancer, antichemotactic and antimicrobial activities of marine sponges collected off the coast of Santa Catarina, southern Brazil Noel R. Monks, Cléa Lerner, Amélia T. Henriques, Journal of Experimental Marine Biology and Ecology Marine SpongesEngineeringMarine PollutionSanta CatarinaOcean Pollution	2002	96
Marine-derived anticancer agents in clinical trials Gilberto Schwartsmann, Adriana Brondani da Rocha, Jane Mattei, Expert Opinion on Investigational Drugs Bioorganic ChemistryChemoprevention StrategyPharmacotherapyAnticancer AgentsMedicinal Chemistry	2003	91
A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies Gilberto Schwartsmann, Luciane Pons DiLeone, Marc E. Horowitz, Investigational New Drugs OncologyBombesin/gastrin-releasing PeptideMedicineAdvanced Solid MalignanciesPeptide Therapeutic	2006	76
Radioresistance is associated to increased Hsp70 content in human glioblastoma cell lines Adriana Brondani da Rocha, Andréa Regner, Ivana Grivicich, International Journal of Oncology Radiation EffectRadiation ExposureCell DeathMolecular BiologyHigh-grade Gliomas	2004	65
Plasma von Willebrand Factor Levels Correlate with Clinical Outcome of Severe Traumatic Brain Injury Clarissa Oliveira De Oliveira, Alexandre Gard Reimer, Adriana Brondani da Rocha, Journal of Neurotrauma	2007	63
Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males Adriana Brondani da Rocha, Rogério Fett Schneider, Gabriel Ribeiro de Freitas, Clinical Chemistry and Laboratory Medicine (CCLM)	2006	61
Synchronous gastrointestinal stromal tumors (GIST) and other primary cancers: Case series of a single institution experience Sheila Ferreira, Gustavo Werutsky, Marcelo Garcia Toneto, International Journal of Surgery	2010	58
Serum Hsp70 as an Early Predictor of Fatal Outcome after Severe Traumatic Brain Injury in Males Adriana Brondani da Rocha, Caroline Zanoni, Gabriel R. de Freitas, Journal of Neurotrauma Traumatic Brain InjuryHead InjuryBrain Injury RehabilitationFatal OutcomeIntracranial Pressure	2005	56
Role of Plasma DNA as a Predictive Marker of Fatal Outcome following Severe Head Injury in Males Virginia Campello Yurgel, Nilo Ikuta, Adriana Brondani da Rocha, Journal of Neurotrauma Traumatic Brain InjuryPlasma DnaLaboratory HematologyClinical InjuryMedicine	2007	56

Page 1